Skip to main content
Caplight Logo









Stratum Biosciences

Stratum Biosciences

Private
New York City, New YorkHealthcare & Life Scienceshttps://stratumbio.com/

Last Round

Seed

Mar 27, 2026

Total Funding Raised

$2M

Company Overview

Stratum Biosciences is a biotechnology company that operates an AI-powered skin biology discovery platform to develop novel active ingredients and formulations for cosmetic and pharmaceutical skin products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Fashion & Beauty, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Revenue Share

AI Layer

Application

Keywords

biotechnologyAI drug discoverydermatology researchbiobankactive ingredientsskincare formulationin silico discoveryskin biomarkersdrug discovery platformlongevity researchmolecular deliverylab-in-the-loopcosmetic sciencebiotech discoverybeauty tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stratum Biosciences Comparables

Compare Stratum Biosciences with similar companies based on industry and business-model similarity.

Stratum Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Outer Biosciences
87%
Debut
77%
BELANO medical AG
63%

Stratum Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 27, 2026

Key People

Founding team and executive leadership

Ross Lane Pearlman

Chief Executive Officer, Co-Founder

Founding Team

Stratum Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    Grew 63% QoQ, from 8 to 13 employees.

  • Apr 21, 2026

    Monthly visitors increased 62% MoM.

Stratum Biosciences Filings

Explore SEC and related filing metadata, where available.

Stratum Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Stratum Biosciences's valuation, stock price, and market status.

Is Stratum Biosciences a public or private company?

Stratum Biosciences is a private company.

What is the current stock price of Stratum Biosciences?

Stratum Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Stratum Biosciences worth (valuation)?

Valuation information for Stratum Biosciences is not publicly available.

Can I buy Stratum Biosciences stock?

Stratum Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Stratum Biosciences's last funding round?

Stratum Biosciences's most recent funding round was Seed on March 27, 2026.

Who are the main investors in Stratum Biosciences?

Key investors in Stratum Biosciences include Harvard Business School Alumni Angels of Greater New York, Johnson & Johnson Innovation - JLABS, Nvidia Inception, Skin Angels.

Will Stratum Biosciences IPO soon?

No public IPO plans have been announced for Stratum Biosciences.

How can I track Stratum Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stratum Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range12
Year Founded2024
Last FundingMar 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?